newsIntravacc publishes GMP vaccine candidate manufacturing process23 March 2022 | By Hannah Balfour (European Pharmaceutical Review)A new paper details the GMP manufacturing and formulation process for a semi-synthetic Shigella glycoconjugate vaccine candidate from Institut Pasteur.